Pre-diabetes: opportunity or overdiagnosis?
- 28 March 2018
- journal article
- editorial
- Published by Royal College of General Practitioners in British Journal of General Practice
- Vol. 68 (669) , 172-173
Abstract
Pre-diabetes is a term used to describe the state where blood glucose levels are above normal but below the threshold for diagnosis of diabetes. An estimated 1 in 3 of the adult population of the UK fall into this group.1 The addition of a coded entry for pre-diabetes to aid adherence to National Institute for Health and Care Excellence (NICE) guidance on follow-up of ‘at risk’ groups is embedding this label within increasing numbers of patients’ lifelong medical records. This article discusses the meaning and significance of this new ‘diagnosis’ at individual and societal level, the controversy that surrounds it, and implications for policy, practice, and research. In the UK pre-diabetes is usually diagnosed on the basis of an HbA1c level of 42–47 mmol/mol.2 The term is also used to encompass patients identified as being at high risk of diabetes by other testing strategies such as fasting glucose or the oral glucose tolerance test (OGTT). The groups identified as abnormal by different testing strategies do not entirely overlap and there is ongoing debate about which diagnostic test is most appropriate and what the cut-offs should be.3 Despite the limitations of HbA1c in certain groups and its poor sensitivity and specificity if the OGTT is taken as the gold standard,4 its ease of use makes it the most commonly used diagnostic test. It is estimated that 5–10% of pre-diabetic patients will become diabetic each year with a similar percentage reverting …Keywords
This publication has 10 references indexed in Scilit:
- Efficacy and effectiveness of screen and treat policies in prevention of type 2 diabetes: systematic review and meta-analysis of screening tests and interventionsBMJ, 2017
- The Long-Term Safety, Public Health Impact, and Cost-Effectiveness of Routine Vaccination with a Recombinant, Live-Attenuated Dengue Vaccine (Dengvaxia): A Model Comparison StudyPLOS Medicine, 2016
- Engagement, Retention, and Progression to Type 2 Diabetes: A Retrospective Analysis of the Cluster-Randomised "Let's Prevent Diabetes" TrialPLOS Medicine, 2016
- A community based primary prevention programme for type 2 diabetes integrating identification and lifestyle intervention for prevention: the Let's Prevent Diabetes cluster randomised controlled trialPreventive Medicine, 2016
- Non-disclosure of chronic kidney disease in primary care and the limits of instrumental rationality in chronic illness self-managementSocial Science & Medicine, 2015
- Prediabetes diagnosis and treatment: A reviewWorld Journal of Diabetes, 2015
- Prevalence of prediabetes in England from 2003 to 2011: population-based, cross-sectional studyBMJ Open, 2014
- Prediabetes: a high-risk state for diabetes developmentThe Lancet, 2012
- 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes StudyThe Lancet, 2009
- The Finnish Diabetes Prevention Study (DPS)Diabetes Care, 2003